attachment
attachment
attachment
attachment
attachment

Explain to me this in English and give high yield notes

Reading File
Finding Sources
The slides are in Chinese from Hebei Medical University. I have a clear view of all 5 images. Let me provide a comprehensive English explanation with high-yield notes directly from the content shown.

Factors Affecting Antigen Immunogenicity (影响抗原免疫原性的因素)


Overview

The lecture covers Section 2: Factors Affecting Antigen Immunogenicity, divided into three major categories:
  1. Physicochemical & structural properties of the antigen molecule
  2. Host characteristics
  3. Route of antigen entry into the body

Part I — Physicochemical & Structural Properties of the Antigen Molecule

1. Foreignness (异物性) — THE #1 REQUIREMENT for an antigen

The immune system's job is to recognize and reject foreign substances (异物).
A substance is "foreign" if:
  • Its chemical structure differs from the host's own components, OR
  • It was never encountered by immune cells during the embryonic period (not recognized as "self")
Key rule: The more evolutionarily distant the antigen source is from the host → greater structural difference → stronger foreignness → stronger immunogenicity

Three categories of foreign substances:

CategoryExample
Xenogeneic (异种物质) — from another speciesBacterial proteins, animal sera — strongest immunogens
Allogenic (同种异体物质) — same species, different individualBlood group antigens (ABO), HLA (human leukocyte antigens)
Self antigens (自身成分)Normally non-immunogenic, but become immunogenic when: (1) structure altered by infection, trauma, radiation, or drugs; (2) sequestered antigens released (sperm, brain tissue, lens crystallin proteins)
⚠️ High Yield: Sequestered antigens (精子, 脑组织, 眼晶状体蛋白) are physically isolated from the immune system. If released (e.g., trauma), they are treated as "foreign" and can trigger autoimmune disease.

2. Chemical Modification Properties (化学修饰属性)

  • The chemical nature and functional groups of an antigen determine its immunogenicity.
  • Immune cells most commonly recognize proteins — also polysaccharides, lipids, nucleic acids.
  • Ranking: Proteins > Polysaccharides > Lipids/Nucleic acids (weakest)
  • Mammalian nuclear components (DNA, histones) are normally non-immunogenic in healthy cells.
    • However, after cell death/activation → DNA undergoes hypomethylation and structural changes → becomes immunogenic → can trigger autoantibodies (relevant to SLE/lupus)
⚠️ High Yield: Proteins are the most potent immunogens. Polysaccharides are moderate. Pure lipids and nucleic acids are generally poor immunogens unless modified.

3. Physical State & Molecular Structure (物理性状与分子结构)

Molecular Weight — Critical Factor

Molecular WeightClassification
> 10 kDaImmunogen (免疫原)
> 100 kDaStrong immunogen (强免疫原)
< 10 kDaPoor immunogen (弱免疫原) / hapten
Why does higher MW = stronger immunogenicity?
  • More epitopes (antigen-binding sites) available
  • More stable molecular structure
  • Harder to be degraded and cleared
  • Stronger stimulation of lymphocytes → stronger immune response

Classic Examples:

  • Gelatin (明胶), MW = 100 kDa: Despite its large size, it consists only of straight-chain amino acids → very weak immunogenicity
    • Add aromatic amino acids (benzene ring groups, 2% tyrosine) → immunogenicity dramatically increases
  • Insulin (胰岛素), MW = only 5.7 kDa: Despite small size, contains complex aromatic amino acids → still relatively immunogenic
⚠️ High Yield: MW alone doesn't determine immunogenicity — chemical complexity (especially aromatic amino acids) matters equally.

Physical State:

  • Particulate antigens (颗粒性抗原) — stronger immunogenicity
  • Soluble antigens (可溶性抗原) — weaker immunogenicity
  • Attaching soluble antigens to particle surfaces increases their immunogenicity (this is the principle behind some vaccine adjuvants/carriers)

4. Spatial Conformation (空间构象)

  • The 3D shape of the epitope is a key factor affecting immunogenicity.
  • BCR (B cell receptor) and antibodies recognize the 3D surface shape of the antigen.
  • Chemical group type, position, and spatial arrangement all significantly affect immune reactivity.
Experimental evidence (tables in slides):
  • Aminobenzene sulfonic acid → strong reaction (+++)
  • Aminobenzene arsenic acid → weak reaction (+)
  • Aminobenzene acetic acid → minimal (+/−)
Position effect:
  • Meta-position aminobenzene sulfonic acid: +++
  • Para-position: +/−
  • Ortho-position: ++
⚠️ High Yield: A single change in the position of a chemical group on the epitope can dramatically change the strength of immune recognition. This shows that immune recognition is exquisitely specific for 3D conformation.

5. Accessibility (易接近性)

  • Defined as: how accessible the epitope is to BCR in 3D space
  • Epitopes that are exposed on the surface of the antigen molecule are more easily recognized → stronger immunogenicity
  • Buried or hidden epitopes are not recognized → poor immunogenicity
Diagram shows: amino acid residues positioned at the tips of protruding structures (+++), vs. those buried or flat (±), demonstrate this concept directly.

Part II — Host Characteristics (宿主的特性)

1. Genetic Factors (遗传因素)

  • The immune response capacity is controlled by multiple genes, especially MHC (Major Histocompatibility Complex) genes — in humans called HLA genes
  • Different mice strains and different individual humans respond differently to the same antigen
  • MHC determines which peptide epitopes get presented to T cells
⚠️ High Yield: MHC/HLA is the genetic controller of immune responsiveness. This explains why vaccines don't work equally in everyone.

2. Age, Sex & Health Status (年龄、性别与健康状态)

FactorEffect
Young adultsStrongest immune response
Young children & elderlyWeaker immune response
Female > MaleFemales generally mount stronger immune responses
Pregnancy, infectionImmune response is suppressed (reduced)
⚠️ High Yield: This explains why vaccines are less effective in the very young, elderly, pregnant women, and immunocompromised individuals.

Part III — Route of Antigen Entry (抗原进入机体方式的影响)

Factors include: dose, route, number of exposures, frequency, and use of adjuvants

1. Dose

  • Too high OR too lowimmune non-responsiveness (tolerance/耐受) is induced
  • Optimal dose → best immune response

2. Route of Entry (ranked by immunogenicity, lowest → highest):

Oral < Intravenous (IV) < Intraperitoneal < Intramuscular < Subcutaneous < Intradermal
  • Intradermal injection (皮内注射) → strongest immune response (most dendritic cells in dermis)
  • Oral route → weakest systemic immune response (may induce oral tolerance)

3. Adjuvants (佐剂)

  • Alum adjuvant (铝佐剂) → preferentially stimulates IgG production
  • Adjuvants generally enhance and prolong immune responses
⚠️ High Yield: The route of antigen administration is clinically critical for vaccine design. Intradermal > Subcutaneous > Intramuscular for immunogenicity. Alum adjuvant promotes IgG.

🔑 Master Summary Table — High-Yield Points

FactorHigh-Yield Fact
Foreignness#1 requirement; more evolutionarily distant = stronger Ag
Sequestered antigensSperm, brain, lens → autoimmune if released
Best immunogen typeProteins > Polysaccharides > Lipids/Nucleic acids
Molecular weight>10 kDa needed; >100 kDa = strong immunogen
Gelatin paradox100 kDa but weak (no aromatic AAs); add tyrosine → strong
Insulin paradoxOnly 5.7 kDa but strong (has aromatic AAs)
Physical stateParticulate > Soluble; adsorbing soluble Ag onto particles ↑ immunogenicity
Epitope positionChanging chemical group position dramatically changes immune reactivity
AccessibilitySurface-exposed epitopes = stronger immunogenicity
MHC/HLAControls genetic responsiveness to antigens
AgeYoung adults > children & elderly
SexFemales > Males in immune response
Best injection routeIntradermal > Subcutaneous > Intramuscular > Intraperitoneal > IV > Oral
Dose extremesToo high or too low dose → immune tolerance
Alum adjuvantPromotes IgG class
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment

Explain to me this in English and give high yield notes

Antigen Presenting Cells (抗原提呈细胞 — APC)


Section 1 — Concept of APCs

An Antigen Presenting Cell (APC) is a cell that:
  1. Takes up an antigen
  2. Processes it into antigenic peptides
  3. Loads those peptides onto MHC molecules (forming a peptide-MHC complex)
  4. Displays this complex on the cell surface
  5. Gets recognized by T cells → triggering an immune response
APCs are central to immune recognition, immune response, and immune regulation.

Section 2 — Classification of APCs

Two Major Types Based on MHC Class Used:

TypeMHC UsedAntigen SourceRecognized by
Type 1 APC (narrow definition)MHC IIExogenous antigens (outside the cell)CD4⁺ T cells (T helper)
Type 2 APC (broad definition)MHC IEndogenous antigens (inside the cell)CD8⁺ T cells (cytotoxic T cells)
⚠️ High Yield: MHC II → exogenous antigens → CD4⁺ T cells. MHC I → endogenous antigens → CD8⁺ T cells. This is one of the most tested concepts in immunology.

Type 1 APCs (MHC II — presenting exogenous antigens)

(1) Professional APCs (专职性APC)

Constitutively (always) express MHC II, co-stimulatory molecules, and adhesion molecules. They can directly capture, process, and present antigens.
The three professional APCs are:
CellKey Feature
Dendritic cells (DC)Strongest APC in the body
Macrophages (Mφ)Present to activated/memory T cells
B lymphocytesConcentrate antigen via BCR; present in lymph nodes

(2) Non-Professional APCs (非专职性APC)

  • Do not normally express MHC II
  • Can be induced to express MHC II during inflammation or by cytokines
  • Much weaker antigen-processing and presenting ability
  • Examples: endothelial cells, epithelial cells, fibroblasts

Type 2 APC — "Target cells" (靶细胞) presenting endogenous antigens via MHC I

  • Any cell infected by an intracellular pathogen or containing mutant proteins (tumor cells)
  • Presents endogenous peptides via MHC I to CD8⁺ T cells → T cell kills the target cell
  • This is the broad definition of APC

Section 3 — Professional APCs in Detail


(一) Dendritic Cells (树突状细胞, DC)

DC = The most powerful APC in the body
DCs are the initiators of adaptive immunity and the bridge between innate and adaptive immunity.

1. Types of DCs (by origin):

TypeFull NameOrigin
cDCConventional DCBone marrow common myeloid progenitor
pDCPlasmacytoid DCCommon lymphoid progenitor
moDCMonocyte-derived DCMonocytes
⚠️ High Yield: DC is the ONLY APC that can directly activate naïve (virgin) T cells. Macrophages and B cells can only activate already-activated or memory T cells.

2. Maturation Stages of cDC:

StageLocationKey Features
Immature DCPeripheral non-lymphoid tissues (skin, mucosa)High PRR expression; strong antigen capture; low MHC II & co-stimulatory molecules
Migratory DCIn transit via lymphatics/bloodProcessing antigen en route
Mature DCPeripheral lymphoid organs (lymph nodes, spleen)Low antigen capture; high MHC II, co-stimulatory molecules, adhesion molecules; strong antigen presentation

Comparison Table — Immature vs. Mature DC:

FeatureImmature DCMature DC
Fc receptors++−/+
Mannose receptors++−/+
MHC II expression+++
Half-life~10 hours>100 hours
MHC II surface molecules10⁶7×10⁶
Co-stimulatory molecules−/+++
Antigen capture/processing++−/+
Antigen presentation ability−/+++
Main functionCapture antigenPresent antigen
⚠️ High Yield: Immature DC = expert at capturing antigen. Mature DC = expert at presenting antigen. These are inverse relationships — memorize this table.

Immature DCs by Location:

LocationFunction
MucosaCapture antigen locally → mature → induce mucosal immune response
ThymusCapture self-antigens → present to developing T cells → induce central immune tolerance (negative selection)
Peripheral lymphoid organsCapture antigens entering lymph nodes/spleen → mature → initiate adaptive immunity

3. Functions of DCs:

  1. Recognize and capture antigens → participate in innate immunity
  2. Process and present antigensinitiate adaptive immunity ← (most important function)
  3. Immune regulation → secrete cytokines and chemokines (e.g., IL-12 drives Th0 → Th1 differentiation)
  4. Induce and maintain immune tolerance:
    • Immature DC → peripheral immune tolerance
    • Thymic DC → central immune tolerance (deletes self-reactive T cell clones via negative selection)
Why can DC uniquely activate naïve T cells?
  • Signal 1: Provides peptide-MHC complex (TCR binding)
  • Signal 2: High expression of CD80, CD86, CD40 (co-stimulatory molecules)
  • Signal 3: Secretes cytokines + high expression of adhesion molecules → fully initiates immune response

(二) Macrophages (巨噬细胞, Mφ)

  • Cannot directly present antigen to naïve T cells
  • Instead, present antigen to activated T cells or effector T cells at sites of infection/injury
  • Antigen presenting ability is significantly weaker than DC
  • Key feedback loop: Macrophages activate T cells → activated T cells secrete IFN-γ → IFN-γ feeds back to further activate macrophages
  • Therefore: the significance of macrophage antigen presentation is to amplify and enhance its own function
⚠️ High Yield: Mφ presents to activated/memory T cells (NOT naïve T cells). DC presents to naïve T cells. IFN-γ from T cells activates Mφ in a positive feedback loop.

(三) B Lymphocytes (B细胞)

  • B cells have no phagocytic ability
  • Antigen uptake methods:
    1. Non-specific pinocytosis (minor)
    2. BCR-mediated specific uptake — BCR on the B cell surface recognizes and binds antigen → antigen is internalized → processed inside → presented as peptide-MHC II complex to CD4⁺ Th cells
  • B cell APC function is especially important when antigen concentration is LOW
B cell antigen presentation cycle:
  1. B cell BCR binds antigen → internalizes and processes it
  2. Presents peptide-MHC II to CD4⁺ T helper cell
  3. Activated T cell expresses CD40L → binds CD40 on B cell → provides Signal 2 to B cell
  4. B cell fully activates + proliferates + differentiates into plasma cells → secretes antibodies
  5. Critical for humoral immune response (especially against T-dependent antigens, TD-Ag)
⚠️ High Yield: B cell APC function happens mainly in lymph nodes. B cells present to CD4⁺ Th cells to get help for antibody production. CD40-CD40L interaction = Signal 2 for B cell activation.

Summary Comparison — The 3 Professional APCs

FeatureDendritic Cell (DC)Macrophage (Mφ)B Cell
Antigen uptakePhagocytosis, pinocytosis, receptor-mediatedPhagocytosis (strongest)BCR-specific + pinocytosis
Presents toNaïve T cellsActivated/Memory T cellsCD4⁺ T helper cells
Result of presentationNaïve T → effector T (Th + CTL)Mφ activation (enhanced cellular immunity)B cell activation → antibodies (humoral immunity)
MHC II expressionConstitutive (high on mature DC)ConstitutiveConstitutive
Antigen presenting strengthStrongestModerateWeaker (important at low Ag conc.)
Unique roleBridge innate & adaptive; ONLY activates naïve TAmplifies its own function via IFN-γ feedbackKey for TD-Ag antibody production

🔑 High-Yield Master Notes

Key FactDetail
APC definitionProcesses antigen → peptide-MHC complex → presents to T cells
MHC II → CD4⁺ TExogenous antigens; professional APCs
MHC I → CD8⁺ TEndogenous antigens; ALL nucleated cells (broad APC)
Strongest APCDendritic cell (DC)
Only APC that activates naïve T cellsDC — macrophages and B cells cannot
Immature DCFound in tissues; captures antigen well; low MHC II
Mature DCFound in lymphoid organs; presents antigen well; high MHC II + co-stimulatory molecules
Thymic DCNegative selection → central tolerance
Peripheral immature DCPeripheral tolerance
MHC II half-life differenceImmature DC ~10h; Mature DC >100h
Macrophage APC significanceIFN-γ feedback → amplifies macrophage function
B cell APC importanceMost important at low antigen concentrations
B cell Signal 2CD40L (T cell) + CD40 (B cell)
DC cytokine exampleIL-12 → drives Th0 → Th1 differentiation
Non-professional APC examplesEndothelial cells, epithelial cells, fibroblasts
Non-professional APC activationInduced by inflammation or cytokines to express MHC II
This is a shared conversation. Sign in to Orris to start your own chat.